Biomerieux SAEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 72.85 EUR | 126,562 EUR | 65,6 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 117.954.114 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Biomerieux SA
Mitarbeiter 14.562
Handelsplatz PA
Ticker Symbol BIM
IPO Datum -
Adresse 376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Webseite https://www.biomerieux.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Pierre Boulud | Chief Executive Officer |
| 2 | Mr. Guillaume Bouhours | Executive VP of Finance, Purchasing and Information Systems & CFO |
| 3 | Ms. Audrey Dauvet | Executive Vice President of Legal, Corporate Integrity & Public Affairs |
| 4 | Ms. Valerie Leylde | Executive Vice President of Human Resources, Communications & CSR |
| 5 | Mr. Pierre Charbonnier | Executive Vice President of Global Quality, Manufacturing & Supply Chain |
| 6 | Mr. Yasha Mitrotti | Executive Vice President of Industrial Applications |
| 7 | Mr. Frederic Beseme | Head of CSR |
| 8 | Ms. Jennifer Zinn | Executive Vice President of Clinical Operations |
| 9 | Dr. Charles K. Cooper | Executive VP of Medical Affairs & Chief Medical Officer |
| 10 | Ms. Celine Roger-Dalbert | Executive Vice President of Research & Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.